Armistice Capital »

Iqvia Holdings shares owned by Armistice Capital

Quarter-by-quarter ownership of Iqvia Holdings (IQV) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Iqvia Holdings

Tip: Access up to 7 years of quarterly data

All positions including Iqvia Holdings held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Iqvia Holdings by Armistice Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $10M 61k 170.54

More positions owned by Armistice Capital

State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Agios Pharmaceuticals (AGIO)
Cytokinetics Com New (CYTK)
Ptc Therapeutics I (PTCT)
Travere Therapeutics (TVTX)
Madrigal Pharmaceuticals (MDGL)
Immunovant (IMVT)
Supernus Pharmaceuticals (SUPN)
Neurocrine Biosciences (NBIX)
Freshpet (FRPT)
Incyte Corporation (INCY)
Dyne Therapeutics (DYN)
Amazon (AMZN)
Ironwood Pharmaceuticals Com Cl A (IRWD)

View all positions for Armistice Capital

Top funds holding Iqvia Holdings

Vanguard Group
BlackRock
Harris Associates L.P
Vanguard Capital Management
Vanguard Portfolio Management
State Street Corporation
Artisan Partners Limited Partnership
Geode Capital Management
Robeco Investment Management
Invesco
Alliancebernstein
Morgan Stanley
Canada Pension Plan Investment Board
Longview Partners
Lazard Asset Management

View all funds holding Iqvia Holdings